Indivior announced that it would discontinue sales of its schizophrenia drug Perseris and cut about 130 jobs, lowering its profit forecast for the year. <\/p>\n\n\n\n
The company’s London-listed shares are expected to fall by about 10 percent, according to pre-market indications. <\/p>\n\n\n\n
Indivior adjusted its operating profit forecast to between $285 million and $320 million, down from the previous $330 million to $380 million range. <\/p>\n\n\n\n
CEO<\/a><\/strong> Mark Crossley cited higher anticipated payer management costs as making Perseris production “no longer financially viable.”<\/p>\n\n\n\n Last month, Indivior moved its primary listing to the US, reflecting its US-focused treatments and investor base, which now accounts for nearly 50 percent of its shareholders. <\/p>\n\n\n\n Need Career Advice? <\/strong>Get employment skills advice at all levels of your career<\/strong><\/a><\/p>\n\n\n\n The company noted net revenue for its opioid treatment drug SUBLOCADE has been more impacted than expected.<\/p>\n\n\n\n It is due to the end of COVID-19 emergency measures related to automatic Medicaid coverage renewals.<\/p>\n\n\n\n Follow us on <\/strong>YouTube<\/strong><\/a>, <\/strong>X<\/strong><\/a>, <\/strong>LinkedIn<\/strong><\/a>, and <\/strong>Facebook<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Indivior announced that it would discontinue sales of its schizophrenia drug Perseris and cut about 130 jobs, lowering its profit forecast for the year. <\/p>\n","protected":false},"author":5,"featured_media":62385,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[415,3,414],"tags":[],"class_list":["post-62384","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uk-employment-news","category-business-news","category-uk-business-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.whatjobs.com\/news\/wp-json\/wp\/v2\/posts\/62384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.whatjobs.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.whatjobs.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.whatjobs.com\/news\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.whatjobs.com\/news\/wp-json\/wp\/v2\/comments?post=62384"}],"version-history":[{"count":0,"href":"https:\/\/www.whatjobs.com\/news\/wp-json\/wp\/v2\/posts\/62384\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.whatjobs.com\/news\/wp-json\/wp\/v2\/media\/62385"}],"wp:attachment":[{"href":"https:\/\/www.whatjobs.com\/news\/wp-json\/wp\/v2\/media?parent=62384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.whatjobs.com\/news\/wp-json\/wp\/v2\/categories?post=62384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.whatjobs.com\/news\/wp-json\/wp\/v2\/tags?post=62384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}